Marwan Abdulaal is an Ophthalmology physician. OpenAlex indexes 25 publications with 427 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
563 Wessel Dr
Fairfield, OH 450143668
Telephone
513-858-6500Provider last certified this registry record 22 Feb 2023.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202516 payments
- Genentech USA, Inc.Program year20257 payments
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
90%Antineovascularisation agents76.9%Faricimab-svoa100%Part B, office-administered≥80 patientsComplement Inhibitor11.4%Avacincaptad pegol100%Part B, office-administered≥31 patients+ 8 more classes in this area
Cancer & immunology
9.3%Vascular Endothelial Growth Factor Inhibitor9.3%Aflibercept100%Part B, office-administered≥236 patientsAnti-infectives
0.3%Macrolide0.3%Erythromycin100%Part D≥69 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes
Canadian Journal of Ophthalmology
2023 - Retinal neovascularization in the setting of <i>CALR</i>-mutation positive essential thrombocythemia
SAGE Open Medical Case Reports
2023 - Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis
Middle East African Journal of Ophthalmology
2021 - Subretinal Pneumatic Displacement without Tissue Plasminogen Activator for Submacular Hemorrhage: One-year Outcomes.
Investigative Ophthalmology & Visual Science
2021 - Comparison of SDOCT Scan Types for Grading Disorganization of Retinal Inner Layers and Other Morphologic Features of Diabetic Macular Edema
Translational Vision Science & Technology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”